Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fat Emulsions, Intravenous | 61 | 2022 | 314 | 10.810 |
Why?
|
Parenteral Nutrition | 83 | 2022 | 640 | 10.650 |
Why?
|
Fish Oils | 51 | 2022 | 454 | 7.390 |
Why?
|
Intestinal Diseases | 21 | 2022 | 507 | 4.590 |
Why?
|
Soybean Oil | 29 | 2022 | 131 | 4.470 |
Why?
|
Liver Diseases | 28 | 2022 | 1246 | 4.040 |
Why?
|
Cholestasis | 25 | 2022 | 354 | 3.530 |
Why?
|
Short Bowel Syndrome | 19 | 2022 | 296 | 2.350 |
Why?
|
Enteral Nutrition | 23 | 2022 | 725 | 1.870 |
Why?
|
Fatty Acids, Essential | 16 | 2020 | 95 | 1.810 |
Why?
|
Parenteral Nutrition, Total | 13 | 2022 | 310 | 1.790 |
Why?
|
Parenteral Nutrition Solutions | 10 | 2021 | 28 | 1.440 |
Why?
|
Aluminum | 4 | 2017 | 137 | 1.360 |
Why?
|
Pharmacy Service, Hospital | 3 | 2019 | 133 | 0.980 |
Why?
|
Nutritional Requirements | 5 | 2019 | 289 | 0.940 |
Why?
|
Fatty Acids, Omega-3 | 15 | 2019 | 1267 | 0.850 |
Why?
|
Dietary Fats | 11 | 2019 | 2042 | 0.840 |
Why?
|
Parenteral Nutrition, Home | 5 | 2021 | 29 | 0.770 |
Why?
|
Drug Contamination | 2 | 2014 | 151 | 0.760 |
Why?
|
Growth | 3 | 2020 | 393 | 0.760 |
Why?
|
Deficiency Diseases | 3 | 2017 | 73 | 0.710 |
Why?
|
Triglycerides | 17 | 2021 | 2564 | 0.710 |
Why?
|
Bilirubin | 10 | 2017 | 392 | 0.700 |
Why?
|
Intestines | 7 | 2022 | 1929 | 0.700 |
Why?
|
Infant Nutritional Physiological Phenomena | 7 | 2021 | 325 | 0.670 |
Why?
|
Infant Nutrition Disorders | 1 | 2017 | 82 | 0.640 |
Why?
|
Liver Failure | 5 | 2022 | 233 | 0.640 |
Why?
|
Infant | 45 | 2022 | 34261 | 0.620 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2017 | 303 | 0.610 |
Why?
|
Dietary Supplements | 10 | 2017 | 3025 | 0.590 |
Why?
|
Micronutrients | 3 | 2017 | 362 | 0.580 |
Why?
|
Nutritional Status | 6 | 2022 | 1532 | 0.580 |
Why?
|
Catheter-Related Infections | 6 | 2020 | 239 | 0.570 |
Why?
|
Child Nutrition Disorders | 1 | 2017 | 171 | 0.570 |
Why?
|
Fatty Liver | 10 | 2019 | 718 | 0.560 |
Why?
|
Gastrointestinal Diseases | 4 | 2019 | 1148 | 0.550 |
Why?
|
Malabsorption Syndromes | 3 | 2019 | 141 | 0.520 |
Why?
|
Infant, Premature | 8 | 2021 | 1989 | 0.520 |
Why?
|
Infant, Premature, Diseases | 6 | 2021 | 700 | 0.500 |
Why?
|
Infant, Newborn | 33 | 2022 | 24433 | 0.500 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2019 | 720 | 0.490 |
Why?
|
Infant, Very Low Birth Weight | 3 | 2021 | 423 | 0.480 |
Why?
|
Swimming | 1 | 2013 | 201 | 0.470 |
Why?
|
Critical Illness | 6 | 2022 | 2496 | 0.440 |
Why?
|
Docosahexaenoic Acids | 8 | 2017 | 846 | 0.430 |
Why?
|
Child Development | 4 | 2019 | 2177 | 0.430 |
Why?
|
Drug Compounding | 5 | 2020 | 245 | 0.420 |
Why?
|
Catheterization, Central Venous | 6 | 2020 | 511 | 0.380 |
Why?
|
Aspartate Aminotransferases | 4 | 2020 | 413 | 0.380 |
Why?
|
alpha-Tocopherol | 3 | 2019 | 131 | 0.380 |
Why?
|
Food, Formulated | 1 | 2010 | 116 | 0.380 |
Why?
|
Fatty Acids | 9 | 2022 | 1741 | 0.380 |
Why?
|
Energy Intake | 8 | 2020 | 2136 | 0.360 |
Why?
|
Arachidonic Acid | 5 | 2017 | 436 | 0.340 |
Why?
|
Protective Agents | 2 | 2019 | 164 | 0.330 |
Why?
|
Child | 39 | 2022 | 73636 | 0.330 |
Why?
|
Intestinal Absorption | 3 | 2019 | 437 | 0.320 |
Why?
|
Medication Errors | 4 | 2017 | 772 | 0.320 |
Why?
|
Humans | 119 | 2022 | 708843 | 0.320 |
Why?
|
Phytosterols | 4 | 2019 | 58 | 0.300 |
Why?
|
Bone Diseases, Metabolic | 3 | 2014 | 398 | 0.300 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 359 | 0.290 |
Why?
|
Child, Preschool | 20 | 2020 | 41081 | 0.290 |
Why?
|
Hyperlipidemias | 1 | 2010 | 796 | 0.280 |
Why?
|
Practice Guidelines as Topic | 9 | 2021 | 7487 | 0.270 |
Why?
|
Hypertriglyceridemia | 1 | 2007 | 292 | 0.270 |
Why?
|
Plant Oils | 5 | 2016 | 189 | 0.260 |
Why?
|
Enterocolitis, Necrotizing | 3 | 2012 | 336 | 0.260 |
Why?
|
Drug Incompatibility | 2 | 2021 | 11 | 0.260 |
Why?
|
Infant, Low Birth Weight | 3 | 2012 | 833 | 0.250 |
Why?
|
Alanine Transaminase | 4 | 2018 | 600 | 0.250 |
Why?
|
Liver | 13 | 2022 | 7622 | 0.250 |
Why?
|
Phospholipids | 6 | 2013 | 813 | 0.240 |
Why?
|
Alkaline Phosphatase | 3 | 2017 | 892 | 0.240 |
Why?
|
Linoleic Acid | 3 | 2017 | 131 | 0.230 |
Why?
|
Liver Function Tests | 4 | 2014 | 533 | 0.210 |
Why?
|
Male | 59 | 2022 | 349524 | 0.200 |
Why?
|
Nursing Staff, Hospital | 1 | 2004 | 335 | 0.200 |
Why?
|
Disease Models, Animal | 19 | 2022 | 18375 | 0.200 |
Why?
|
Refeeding Syndrome | 1 | 2020 | 13 | 0.200 |
Why?
|
Antithrombins | 1 | 2022 | 294 | 0.190 |
Why?
|
Drug Evaluation | 1 | 2021 | 661 | 0.190 |
Why?
|
Pharmacists | 2 | 2019 | 220 | 0.190 |
Why?
|
Lipids | 5 | 2012 | 3246 | 0.190 |
Why?
|
Liver Transplantation | 4 | 2020 | 2022 | 0.190 |
Why?
|
Liver Cirrhosis | 4 | 2015 | 1721 | 0.190 |
Why?
|
Treatment Outcome | 18 | 2021 | 61932 | 0.180 |
Why?
|
Recovery of Function | 1 | 2010 | 2950 | 0.180 |
Why?
|
Hospitals, Pediatric | 5 | 2016 | 1776 | 0.180 |
Why?
|
Product Labeling | 1 | 2019 | 85 | 0.180 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2021 | 286 | 0.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2015 | 5135 | 0.170 |
Why?
|
Latex | 1 | 1997 | 61 | 0.170 |
Why?
|
Endotoxemia | 1 | 2019 | 219 | 0.170 |
Why?
|
Nutrition Assessment | 2 | 2020 | 714 | 0.170 |
Why?
|
Mice, Inbred C57BL | 17 | 2022 | 22989 | 0.170 |
Why?
|
gamma-Glutamyltransferase | 1 | 2017 | 129 | 0.160 |
Why?
|
Retrospective Studies | 22 | 2022 | 71483 | 0.160 |
Why?
|
Intubation, Gastrointestinal | 1 | 2018 | 145 | 0.160 |
Why?
|
United States Food and Drug Administration | 3 | 2014 | 1740 | 0.160 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2016 | 1055 | 0.160 |
Why?
|
Vitamin K | 1 | 2019 | 283 | 0.160 |
Why?
|
Nutritional Support | 2 | 2022 | 170 | 0.160 |
Why?
|
Chemistry, Pharmaceutical | 1 | 1997 | 291 | 0.150 |
Why?
|
Infection Control | 1 | 2004 | 959 | 0.150 |
Why?
|
Hepatic Insufficiency | 1 | 2016 | 13 | 0.150 |
Why?
|
Mucolipidoses | 2 | 2019 | 78 | 0.150 |
Why?
|
Case-Control Studies | 4 | 2020 | 21194 | 0.150 |
Why?
|
Energy Metabolism | 4 | 2012 | 2968 | 0.150 |
Why?
|
Emulsions | 5 | 2014 | 147 | 0.150 |
Why?
|
Female | 42 | 2021 | 375205 | 0.150 |
Why?
|
Feeding Methods | 1 | 2016 | 34 | 0.150 |
Why?
|
Pruritus | 1 | 2019 | 334 | 0.150 |
Why?
|
Rest | 2 | 2012 | 868 | 0.150 |
Why?
|
Animals | 37 | 2022 | 170486 | 0.140 |
Why?
|
PPAR gamma | 1 | 2019 | 491 | 0.140 |
Why?
|
Medication Reconciliation | 1 | 2017 | 157 | 0.140 |
Why?
|
Intestine, Small | 1 | 2022 | 1235 | 0.140 |
Why?
|
Environmental Exposure | 1 | 2010 | 3954 | 0.140 |
Why?
|
Dietary Proteins | 1 | 2020 | 967 | 0.140 |
Why?
|
Heparin | 1 | 2022 | 1625 | 0.140 |
Why?
|
Patient Transfer | 1 | 2022 | 759 | 0.140 |
Why?
|
Gastric Emptying | 1 | 2017 | 229 | 0.140 |
Why?
|
Vitamin E | 1 | 2019 | 842 | 0.130 |
Why?
|
Cross Infection | 1 | 2004 | 1412 | 0.130 |
Why?
|
Disease Outbreaks | 1 | 2004 | 1709 | 0.130 |
Why?
|
Weight Gain | 5 | 2020 | 2193 | 0.130 |
Why?
|
Hair | 1 | 2017 | 445 | 0.130 |
Why?
|
Citrulline | 1 | 2014 | 106 | 0.130 |
Why?
|
Ileum | 1 | 2017 | 558 | 0.130 |
Why?
|
Postoperative Care | 2 | 2018 | 1514 | 0.130 |
Why?
|
United States | 17 | 2022 | 67165 | 0.130 |
Why?
|
Sterilization | 1 | 2014 | 136 | 0.120 |
Why?
|
Mucositis | 1 | 2014 | 100 | 0.120 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2014 | 229 | 0.120 |
Why?
|
Malnutrition | 2 | 2016 | 620 | 0.120 |
Why?
|
Fatty Acids, Omega-6 | 3 | 2013 | 224 | 0.120 |
Why?
|
Stomach | 1 | 2017 | 673 | 0.120 |
Why?
|
Medication Systems, Hospital | 1 | 1993 | 160 | 0.110 |
Why?
|
Body Fluid Compartments | 1 | 2011 | 51 | 0.110 |
Why?
|
Infusions, Intravenous | 2 | 2016 | 2303 | 0.110 |
Why?
|
Hyperbilirubinemia | 2 | 2016 | 71 | 0.110 |
Why?
|
Bacteremia | 2 | 2015 | 968 | 0.110 |
Why?
|
Gastrointestinal Tract | 2 | 2016 | 834 | 0.110 |
Why?
|
Health Care Rationing | 1 | 2015 | 455 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1194 | 0.110 |
Why?
|
Mouth Mucosa | 1 | 2014 | 431 | 0.110 |
Why?
|
Adolescent | 15 | 2020 | 84718 | 0.100 |
Why?
|
Lipid Regulating Agents | 1 | 2010 | 25 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2020 | 9488 | 0.100 |
Why?
|
Maximum Allowable Concentration | 1 | 2010 | 59 | 0.100 |
Why?
|
Reperfusion Injury | 1 | 2018 | 1071 | 0.100 |
Why?
|
Cysteine | 1 | 2015 | 861 | 0.100 |
Why?
|
Interleukin-6 | 4 | 2019 | 3179 | 0.100 |
Why?
|
Inflammation | 3 | 2019 | 10019 | 0.100 |
Why?
|
Mice | 20 | 2022 | 80876 | 0.100 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2012 | 530 | 0.100 |
Why?
|
Age Factors | 5 | 2019 | 18712 | 0.100 |
Why?
|
Prospective Studies | 13 | 2021 | 50597 | 0.100 |
Why?
|
Health | 1 | 2012 | 395 | 0.090 |
Why?
|
Vaccines | 1 | 2017 | 719 | 0.090 |
Why?
|
Growth Disorders | 1 | 2014 | 641 | 0.090 |
Why?
|
Hypersensitivity | 1 | 1997 | 1019 | 0.090 |
Why?
|
Food Contamination | 1 | 2010 | 167 | 0.090 |
Why?
|
C-Reactive Protein | 5 | 2020 | 3696 | 0.090 |
Why?
|
Adult | 17 | 2021 | 211041 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1805 | 0.090 |
Why?
|
Eicosapentaenoic Acid | 4 | 2017 | 535 | 0.090 |
Why?
|
Anti-Bacterial Agents | 3 | 2020 | 6991 | 0.090 |
Why?
|
Osmolar Concentration | 1 | 2009 | 711 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2022 | 3866 | 0.090 |
Why?
|
Anti-Infective Agents, Local | 1 | 2010 | 234 | 0.080 |
Why?
|
Streptomyces | 2 | 1997 | 86 | 0.080 |
Why?
|
Biliary Tract | 1 | 2008 | 139 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2340 | 0.080 |
Why?
|
Probability | 2 | 2014 | 2474 | 0.080 |
Why?
|
Family | 1 | 2018 | 3087 | 0.080 |
Why?
|
Risk Factors | 9 | 2020 | 69553 | 0.080 |
Why?
|
Glutamine | 2 | 2012 | 567 | 0.080 |
Why?
|
Serum Albumin | 1 | 2009 | 681 | 0.080 |
Why?
|
Swine | 3 | 2022 | 5763 | 0.070 |
Why?
|
Bone and Bones | 2 | 2014 | 2567 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1662 | 0.070 |
Why?
|
Metabolome | 1 | 2013 | 859 | 0.070 |
Why?
|
Intestinal Volvulus | 1 | 2006 | 55 | 0.070 |
Why?
|
Incidence | 6 | 2022 | 20320 | 0.070 |
Why?
|
Glucose | 4 | 2017 | 4261 | 0.070 |
Why?
|
Electrolytes | 3 | 2017 | 289 | 0.070 |
Why?
|
Immunity | 1 | 2012 | 957 | 0.070 |
Why?
|
Vitamins | 3 | 2022 | 1466 | 0.070 |
Why?
|
Dietary Carbohydrates | 2 | 2012 | 902 | 0.070 |
Why?
|
Cholecystitis, Acute | 1 | 2006 | 65 | 0.070 |
Why?
|
Microvilli | 2 | 2019 | 249 | 0.070 |
Why?
|
Anemia | 1 | 2014 | 1403 | 0.070 |
Why?
|
Societies, Scientific | 2 | 2018 | 212 | 0.070 |
Why?
|
Ceftriaxone | 1 | 2006 | 149 | 0.070 |
Why?
|
Patient Discharge | 1 | 2018 | 2980 | 0.070 |
Why?
|
Consumer Product Safety | 1 | 2006 | 130 | 0.070 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 2945 | 0.070 |
Why?
|
Osteoporosis | 1 | 2015 | 1556 | 0.070 |
Why?
|
Hypoglycemia | 1 | 2011 | 805 | 0.070 |
Why?
|
Body Composition | 2 | 2011 | 2393 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1356 | 0.070 |
Why?
|
Clinical Competence | 2 | 2018 | 4615 | 0.070 |
Why?
|
PPAR alpha | 1 | 2006 | 192 | 0.070 |
Why?
|
Amino Acids | 3 | 2017 | 1752 | 0.070 |
Why?
|
Blood Glucose | 1 | 2019 | 6255 | 0.070 |
Why?
|
Metabolomics | 1 | 2013 | 1357 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5348 | 0.070 |
Why?
|
Cholelithiasis | 1 | 2006 | 416 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2244 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1948 | 0.060 |
Why?
|
Risk Assessment | 3 | 2019 | 23284 | 0.060 |
Why?
|
Ethanol | 1 | 2010 | 1245 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3690 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2011 | 1343 | 0.060 |
Why?
|
Hydroxamic Acids | 1 | 2006 | 507 | 0.060 |
Why?
|
Double-Blind Method | 6 | 2015 | 11877 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2010 | 843 | 0.060 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 293 | 0.060 |
Why?
|
Blood Platelets | 1 | 2013 | 2485 | 0.060 |
Why?
|
Adipose Tissue | 2 | 2011 | 3234 | 0.060 |
Why?
|
Radiotherapy | 1 | 2010 | 1623 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 2818 | 0.060 |
Why?
|
Bone Density | 1 | 2015 | 3395 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 2713 | 0.050 |
Why?
|
Cell Membrane | 3 | 2012 | 3892 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15252 | 0.050 |
Why?
|
Equipment Design | 1 | 2009 | 3627 | 0.050 |
Why?
|
Area Under Curve | 2 | 2017 | 1688 | 0.050 |
Why?
|
Living Donors | 1 | 2005 | 569 | 0.050 |
Why?
|
Safety | 1 | 2005 | 1224 | 0.050 |
Why?
|
Reference Values | 1 | 2008 | 5041 | 0.050 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2022 | 311 | 0.050 |
Why?
|
Parents | 1 | 2013 | 3154 | 0.050 |
Why?
|
Length of Stay | 3 | 2020 | 6257 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 55940 | 0.050 |
Why?
|
Prescriptions | 1 | 2022 | 335 | 0.050 |
Why?
|
Diet | 3 | 2012 | 7392 | 0.050 |
Why?
|
Infant Formula | 1 | 2020 | 202 | 0.050 |
Why?
|
Models, Biological | 1 | 2016 | 9907 | 0.050 |
Why?
|
Lipopolysaccharides | 2 | 2019 | 2264 | 0.050 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1999 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2021 | 297 | 0.040 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2019 | 92 | 0.040 |
Why?
|
Survival Rate | 2 | 2014 | 13202 | 0.040 |
Why?
|
Phosphorus | 1 | 2020 | 357 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2022 | 326 | 0.040 |
Why?
|
Societies, Medical | 3 | 2020 | 3776 | 0.040 |
Why?
|
Spectrophotometry, Atomic | 1 | 2017 | 83 | 0.040 |
Why?
|
Body Mass Index | 2 | 2016 | 12366 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2011 | 1418 | 0.040 |
Why?
|
Time Factors | 7 | 2020 | 41038 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 423 | 0.040 |
Why?
|
Hospitals, Teaching | 1 | 2002 | 1156 | 0.040 |
Why?
|
International Normalized Ratio | 1 | 2019 | 364 | 0.040 |
Why?
|
Anthropometry | 2 | 2015 | 1367 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2016 | 16008 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2021 | 761 | 0.040 |
Why?
|
Filtration | 1 | 2018 | 234 | 0.040 |
Why?
|
Gastrointestinal Contents | 1 | 2017 | 33 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2019 | 4466 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2789 | 0.040 |
Why?
|
alpha-Linolenic Acid | 1 | 2017 | 147 | 0.040 |
Why?
|
Nutritional Sciences | 1 | 2018 | 145 | 0.040 |
Why?
|
Birth Weight | 2 | 2016 | 1893 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6765 | 0.040 |
Why?
|
Magnesium | 1 | 2020 | 852 | 0.040 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 503 | 0.040 |
Why?
|
Pilot Projects | 3 | 2018 | 7994 | 0.040 |
Why?
|
Rats | 3 | 2022 | 25094 | 0.040 |
Why?
|
Safflower Oil | 1 | 2015 | 30 | 0.040 |
Why?
|
Body Weight | 2 | 2018 | 4680 | 0.040 |
Why?
|
Language Development | 1 | 2017 | 196 | 0.040 |
Why?
|
Gastrointestinal Transit | 1 | 2017 | 101 | 0.040 |
Why?
|
Micelles | 1 | 2017 | 221 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 819 | 0.040 |
Why?
|
Potassium | 1 | 2020 | 1375 | 0.040 |
Why?
|
Solutions | 2 | 2011 | 417 | 0.030 |
Why?
|
Infant Food | 1 | 1995 | 147 | 0.030 |
Why?
|
Gastroparesis | 1 | 2017 | 121 | 0.030 |
Why?
|
Vietnam | 1 | 2016 | 385 | 0.030 |
Why?
|
Dietetics | 1 | 2014 | 36 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2015 | 39038 | 0.030 |
Why?
|
Bile Acids and Salts | 1 | 2017 | 349 | 0.030 |
Why?
|
Patient Care Team | 2 | 2022 | 2587 | 0.030 |
Why?
|
Drug Labeling | 1 | 2017 | 258 | 0.030 |
Why?
|
Survival Analysis | 1 | 2008 | 10507 | 0.030 |
Why?
|
Pulmonary Ventilation | 1 | 2016 | 376 | 0.030 |
Why?
|
Motor Skills | 1 | 2017 | 519 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1443 | 0.030 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1993 | 62 | 0.030 |
Why?
|
Vomiting | 1 | 2017 | 626 | 0.030 |
Why?
|
Heart Diseases | 1 | 2006 | 2759 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2012 | 4831 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2399 | 0.030 |
Why?
|
Acetaminophen | 1 | 2017 | 540 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2016 | 623 | 0.030 |
Why?
|
Organ Size | 1 | 2018 | 2317 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1399 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2013 | 311 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2455 | 0.030 |
Why?
|
Membrane Lipids | 1 | 2013 | 253 | 0.030 |
Why?
|
Automation | 1 | 2014 | 589 | 0.030 |
Why?
|
Bacteria | 2 | 2000 | 2040 | 0.030 |
Why?
|
Oxidative Stress | 2 | 2013 | 3156 | 0.030 |
Why?
|
Boston | 2 | 2016 | 9402 | 0.030 |
Why?
|
Diarrhea, Infantile | 1 | 2011 | 127 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13536 | 0.030 |
Why?
|
Education, Medical, Continuing | 1 | 2017 | 868 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2000 | 1423 | 0.030 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2012 | 386 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1472 | 0.030 |
Why?
|
Checklist | 1 | 2018 | 781 | 0.030 |
Why?
|
Instillation, Drug | 1 | 2010 | 34 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2017 | 2877 | 0.030 |
Why?
|
Lung | 2 | 2022 | 9706 | 0.030 |
Why?
|
Arthritis, Rheumatoid | 1 | 2006 | 3609 | 0.030 |
Why?
|
Needs Assessment | 1 | 2017 | 1147 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2015 | 1670 | 0.030 |
Why?
|
Platelet Count | 1 | 2013 | 794 | 0.030 |
Why?
|
Abdomen | 1 | 2017 | 1094 | 0.030 |
Why?
|
Feces | 1 | 2017 | 1365 | 0.030 |
Why?
|
Inclusion Bodies | 1 | 2011 | 277 | 0.030 |
Why?
|
Digestive System Surgical Procedures | 1 | 2016 | 568 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2017 | 1019 | 0.020 |
Why?
|
Diet, Fat-Restricted | 1 | 2012 | 308 | 0.020 |
Why?
|
Adipogenesis | 1 | 2012 | 349 | 0.020 |
Why?
|
Vitamin D | 2 | 2015 | 3138 | 0.020 |
Why?
|
Spleen | 1 | 2016 | 2473 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 178 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 803 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2017 | 2502 | 0.020 |
Why?
|
Reference Standards | 1 | 1993 | 992 | 0.020 |
Why?
|
Critical Care | 1 | 2022 | 2473 | 0.020 |
Why?
|
Milk | 1 | 2012 | 430 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2000 | 6562 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 11239 | 0.020 |
Why?
|
Middle Aged | 3 | 2020 | 213752 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2011 | 15053 | 0.020 |
Why?
|
Probiotics | 1 | 2012 | 339 | 0.020 |
Why?
|
Disease Progression | 2 | 2016 | 13298 | 0.020 |
Why?
|
Arginine | 1 | 2012 | 944 | 0.020 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2008 | 62 | 0.020 |
Why?
|
Lipogenesis | 1 | 2010 | 200 | 0.020 |
Why?
|
Cognition | 2 | 2017 | 5982 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 1997 | 1040 | 0.020 |
Why?
|
Data Collection | 1 | 1997 | 3276 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2000 | 0.020 |
Why?
|
Milk, Human | 1 | 2012 | 464 | 0.020 |
Why?
|
Germany | 1 | 2009 | 791 | 0.020 |
Why?
|
Siblings | 1 | 2012 | 806 | 0.020 |
Why?
|
Caloric Restriction | 1 | 2010 | 348 | 0.020 |
Why?
|
Escherichia coli | 1 | 2019 | 4316 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5986 | 0.020 |
Why?
|
Quality of Life | 1 | 2007 | 11594 | 0.020 |
Why?
|
Mental Disorders | 1 | 2006 | 6395 | 0.020 |
Why?
|
Fibrosis | 1 | 2013 | 1947 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13714 | 0.020 |
Why?
|
Trace Elements | 1 | 2007 | 199 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 23020 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9774 | 0.020 |
Why?
|
Odds Ratio | 2 | 2013 | 9754 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2017 | 2421 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2014 | 952 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2011 | 1692 | 0.020 |
Why?
|
Gestational Age | 1 | 2014 | 3378 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 3944 | 0.020 |
Why?
|
Medical Errors | 1 | 2014 | 1300 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3518 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3104 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2524 | 0.020 |
Why?
|
Cohort Studies | 1 | 2008 | 39292 | 0.020 |
Why?
|
Antioxidants | 1 | 2013 | 1678 | 0.020 |
Why?
|
Premature Birth | 1 | 2016 | 1498 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3074 | 0.020 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2006 | 227 | 0.020 |
Why?
|
Treatment Failure | 1 | 2010 | 2680 | 0.020 |
Why?
|
Patient Readmission | 1 | 2018 | 2952 | 0.020 |
Why?
|
Transcription Factors | 1 | 2004 | 12005 | 0.020 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2004 | 139 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2010 | 1817 | 0.020 |
Why?
|
Breast Feeding | 1 | 2011 | 1273 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8896 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2019 | 15274 | 0.010 |
Why?
|
Mice, Obese | 1 | 2004 | 451 | 0.010 |
Why?
|
Gastrointestinal Agents | 1 | 2007 | 497 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4266 | 0.010 |
Why?
|
Pediatrics | 1 | 2018 | 3554 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3733 | 0.010 |
Why?
|
Signal Transduction | 2 | 2019 | 23950 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12447 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2559 | 0.010 |
Why?
|
Prognosis | 2 | 2016 | 28919 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10339 | 0.010 |
Why?
|
Necrosis | 1 | 2006 | 1646 | 0.010 |
Why?
|
Neutrophils | 1 | 2015 | 3867 | 0.010 |
Why?
|
Retina | 1 | 2012 | 2649 | 0.010 |
Why?
|
Cholesterol | 1 | 2010 | 2866 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 5163 | 0.010 |
Why?
|
Biopsy | 1 | 2013 | 6766 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 1993 | 2277 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 8992 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 2351 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2012 | 1687 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1333 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10566 | 0.010 |
Why?
|
Hospitalization | 2 | 2016 | 9644 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 14712 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12031 | 0.010 |
Why?
|
Postoperative Period | 1 | 2004 | 1843 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 8593 | 0.010 |
Why?
|
Protoplasts | 1 | 1997 | 43 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8024 | 0.010 |
Why?
|
Mycoses | 1 | 2000 | 368 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8712 | 0.010 |
Why?
|
Sepsis | 1 | 2010 | 2449 | 0.010 |
Why?
|
Aged | 2 | 2020 | 161488 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 19423 | 0.010 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2007 | 2137 | 0.010 |
Why?
|
Medical Records | 1 | 2000 | 1410 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2000 | 1900 | 0.010 |
Why?
|
Research Design | 1 | 2010 | 5833 | 0.010 |
Why?
|
Cell Wall | 1 | 1997 | 451 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 1997 | 2244 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2000 | 5235 | 0.000 |
Why?
|
Brain | 1 | 2012 | 24969 | 0.000 |
Why?
|
Algorithms | 1 | 2002 | 13647 | 0.000 |
Why?
|
Neoplasms | 1 | 2010 | 20172 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 34151 | 0.000 |
Why?
|